Dex4
Natural health product licensed in Canada
- Other names
- Dex4 Tablets
- Licence holder
- A.M.G. Medical Inc.
- NPN or DIN-HM
- 80123572
- Status
- Active licence
- Licence date
- 20 March 2023
- Revision date
- 21 April 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| D-Glucose Source : Glucose | 4 g | Not calculated |
| D-Glucose Source : Zea mays - fruit | 4 g | Not calculated |
Non-medicinal ingredients
Acide ascorbique, Acide citrique, Laque d'aluminium bleu FD&C No 2, Saveur de melon d'eau, Acide DL-malique, Stéarate de magnésium, Cellulose, Saveur de raisin, Saveur de framboise, Saveur de chocolat, Saveur de fraise, Rouge allura AC, Saveur de tangerine, Saveur d'orange, Laque d'aluminium jaune FD&C No. 6, Saveur de punch aux fruits, Carmine, Saveur de vanille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 5 years ; maximum: 10 years | minimum: 2 Comprimé ; maximum: 3 Comprimé | Not specified |
| Enfants | minimum: 1 year ; maximum: 4 years | minimum: 1 Comprimé | Not specified |
| Enfants et Adolescents | minimum: 11 years ; maximum: 18 years | minimum: 4 Comprimé | Not specified |
| Adultes | minimum: 18 years | minimum: 4 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For relief of mild to moderate hypoglycemia. Fast and effective relief of mild to moderate hypoglycemia. Fast acting glucose for relief of mild to moderate hypoglycemia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80123572
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.